Results 81 to 90 of about 14,484 (178)

Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned? [PDF]

open access: yesPharmacoecon Open
Rodríguez-Lago I   +6 more
europepmc   +1 more source

Correction: Estimating the Value of Combination Vaccines: A Methodological Framework. [PDF]

open access: yesPharmacoeconomics
Jit M   +4 more
europepmc   +1 more source

Correction: How do Health State Values Differ When Respondents Consider Adults Versus Children Living in Those States? A Systematic Review. [PDF]

open access: yesPharmacoeconomics
De Silva A   +7 more
europepmc   +1 more source

Correction: Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy. [PDF]

open access: yesPharmacoecon Open
Salcedo J   +7 more
europepmc   +1 more source

What is the Value of Developing an HTA Process? [PDF]

open access: yesPharmacoeconomics
Murphy P   +4 more
europepmc   +1 more source

NICE Appraisals of Relugolix-CT and Linzagolix for Endometriosis Symptom Management: Commentary on Clinical and Economic Uncertainties. [PDF]

open access: yesPharmacoeconomics
Qendri V   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy